- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
eMed Technologies postpones IPO plans
eMed Technologies postpones IPO plansTeleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (PNN
eMed Technologies postpones IPO plans
Teleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (
PNN
9/99). Citing a volatile market and Wall Streets recent apprehension about Internet stocks and the healthcare information systems sector in particular, the Lexington, MA-based company opted to delay the offering until the climate improves, according to John Strauss, vice president of marketing.
This is a postponement, Strauss said. We will continue to look at the marketplace, and when the healthcare segment is valued differently, we will consider doing this again.
eMed had hoped to raise more than $57 million through the IPO by selling 3.1 million stocks at $12 to $14/share. Combined with existing private shareholder equity, this would have placed the companys market capitalization at $177 million.
eMeds plans to move in a more Internet-based direction remain unchanged, according to Strauss. The company introduced a Web-based teleradiology and image distribution application earlier this year and plans to debut a new Web-based service for radiologists at the upcoming RSNA meeting.
- Search again
- Homepage
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
